Latest filing published 16 Oct 2017 for SCICLONE PHARMACEUTICALS INC.
Lan Xie appears in our data through filings on Sciclone Pharmaceuticals Inc shares, published by SEC (Form 4). Between 14 August 2013 and 13 October 2017, the trades on record add up to 35 filings.
Every open-market trade on record is a sale: 16 sales worth €953k. Besides market trades, the filings include 18 option exercises. Since January 2017: no purchases and 3 sales on the market.
The latest filing, published on 16 October 2017, reports an option exercise in Sciclone Pharmaceuticals Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 35 declarations